The American Academy of Otolaryngology–Head and Neck Surgery has released updated guidelines on dysphonia management.
A new study concludes that cochlear implantation is commonly performed for indications beyond those included in FDA-approved labeling
Survivors of head and neck cancers are at risk for delayed neurocognitive deficits for at least two years following radiotherapy or chemotherapy
Questions remain regarding the ideal criteria for transfusion in these patients.
There is level 1 evidence that suggests UPPP surgery is an effective treatment for OSA in the appropriately selected patient.
Despite the high prevalence of hearing loss in the United States, researchers of a new study published in JAMA Otolaryngology–Head and Neck Surgery found substantial gaps in specialist referral patterns and the use of amplification options, including hearing aids and cochlear implants (CIs). The researchers, led by Hossein Mahboubi, MD, MPH, a resident in the […]
One in 20 children are prescribed codeine after undergoing tonsillectomy despite FDA black box warning regarding safety and efficacy issues associated with prescribing the opioid to children after these surgeries.
The use of neuromodulators appears to be helpful in patients with chronic idiopathic/ neurogenic cough
The incidence of alteration in taste sensation with coblation lingual tonsillectomy, TORS tongue-base reduction, and submucosal lingualplasty is sufficiently high to warrant warning patients.